&w=3840&q=100)
Govt plans to ease petrol pump licensing norms amid energy security push
The government had in 2019 relaxed the norms for setting up petrol pumps, opening the door for non-oil companies to enter the fuel retailing business.
At that time, companies with a net worth of Rs 250 crore were permitted to sell petrol and diesel, provided they committed to setting up infrastructure for at least one new-generation alternative fuel, such as CNG, LNG, biofuels, or EV charging, within three years of beginning their operations.
For companies wanting to sell petrol and diesel to retail and bulk consumers, the networth criteria was set at Rs 500 crore.
The Ministry of Petroleum and Natural Gas has now constituted an expert committee to review the 2019 guidelines for granting authorisation to market transportation fuels.
The expert committee will "assess the effectiveness of the framework envisaged in Resolution dated November 8, 2019, in ensuring energy security and market efficiency; align the policy framework with national commitment towards decarbonisation, electrical mobility and promotion of alternative fuel; and address issues in implementation of existing guidelines," the order said.
The committee is headed by Sukhmal Jain, former director (marketing) of Bharat Petroleum Corporation Ltd (BPCL). Other members of the four-member committee are Petroleum Planning and Analysis Cell (PPAC) Director General P Manoj Kumar, FIPI member PS Ravi and Arun Kumar, Director (Marketing) in the ministry.
An August 6 notice of the ministry sought stakeholder/general public comments/suggestions on the matter within 14 days.
Prior to the 2019 change, to obtain a fuel retailing license in India, a company had to invest or commit to invest Rs 2,000 crore in either hydrocarbon exploration and production, refining, pipelines or liquefied natural gas (LNG) terminals.
This norm was relaxed in 2019. That year, the government allowed any entity with a net worth of Rs 250 crore to get a licence to retail petrol and diesel to either bulk or retail consumers. For those seeking authorisation for both retail and bulk, the minimum networth was set at Rs 500 crore at the time of application.
For retail authorisation, the entities are required to set up at least 100 retail outlets. Also, retailers are required to establish 5 per cent of the total outlets in rural areas within five years.
Global energy giants have been eyeing the Indian fuel market for a long time.
French energy giant TotalEnergies, in partnership with Adani Group, had in November 2018 applied for a licence to retail petrol and diesel through 1,500 outlets. BP too has formed a partnership with Reliance Industries to set up petrol pumps.
While oil trader Trafigura's downstream arm, Puma Energy, had applied for a license, Saudi Arabia's Aramco has been in talks to enter the sector.
State-owned oil marketing companies Indian Oil Corp (IOC), Bharat Petroleum Corp Ltd (BPCL) and Hindustan Petroleum Corp Ltd (HPCL) currently own most of the 97,804 petrol pumps in the country. Reliance Industries, Nayara Energy (formerly Essar Oil), and Royal Dutch Shell are the private players in the market, but with limited presence.
The joint venture of Reliance, which operates the world's largest oil refining complex, and BP has 1,991 outlets. Nayara has 6,763 pumps, while Shell has just 355. Currently, IOC is the market leader with 40,666 petrol pumps in the country, followed by BPCL with 23,959 outlets, and HPL with 23,901 fuel stations.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Fashion Value Chain
30 minutes ago
- Fashion Value Chain
Solo-Dex and Polymedicure Partner to Bring Opioid-Free Acute Pain Management to India and Major Asian Markets
Solo-Dex, Inc., a U.S.-based medical device innovator, and Polymedicure Ltd. (Polymed), Indias leading manufacturer of high-quality medical devices, today announced a strategic manufacturing and supply partnership to bring Solo-Dexs patented, opioid-free regional anesthesia solutions to hospitals across India for the first time. Under this agreement, Polymed will manufacture Solo-Dexs flagship product, the Fascile Continuous Peripheral Nerve Block system, in accordance with Solo-Dexs strict quality standards, for distribution across India and key global markets. The product is already approved for clinical use in the United States and Europe and is now set to support Indias expanding Enhanced Recovery After Surgery (ERAS) programs and the growth of outpatient surgical care. 'This is a game-changer for pain management in India,' said Steven Eror, CEO of Solo-Dex. 'Polymeds scale, precision, and strong regulatory framework make them the ideal manufacturing partner. Together, well deliver a transformative technology that goes far beyond suppressing pain-it blocks acute pain completely.' First-of-its-kind in India: Faster, Safer, Non-Opioid Pain Control Solo-Dexs patented device installs in under two minutes and enables continuous, localized pain relief without opioids. Unlike conventional methods that may require IV sedation and can result in patient delirium, Solo-Dex minimizes systemic drug exposure, and eliminates the need for oral opioids thereby improving patient safety, reducing recovery time, and decreasing demand on hospital resources. The technology is designed to seamlessly integrate with ERAS protocols, helping hospitals manage post-operative pain more efficiently. As Indias healthcare system increasingly embraces day surgery and outpatient models, Solo-Dex offers a solution that enhances patient throughput and satisfaction without compromising clinical outcomes. 'We are excited to be part of this international collaboration,' said Himanshu Baid, Managing Director of Polymed. 'This partnership not only brings cutting-edge pain management to Indian clinicians and patients, but also aligns with our commitment to making world-class healthcare more accessible.' Designed for Global Impact Manufacturing will take place in Polymeds ISO 13485-certified, FDA-auditable facilities, with initial orders for 100,000 units. In addition to serving India, the partnership aims to fulfill international demand across Asia, Africa, Latin America, and select European markets, with Solo-Dex overseeing global regulatory compliance and branding. 'Thanks to this agreement, Solo-Dex now has the scalable, cost-effective production capacity to meet global demand while maintaining the clinical precision and quality our technology requires,' said Eror. 'Were especially proud to collaborate with Polymed to address the worldwide need for safer, opioid-free surgical recovery.' The Solo-Dex and Polymed partnership is already engaging with leading hospital systems across India, with commercial availability expected to begin in Q4 2025. About Solo-Dex, Inc. Solo-Dex is a U.S.-based medical device company focused on opioid-free acute pain management. Its patented continuous peripheral nerve block systems enable anesthesiologists to deliver localized, long-lasting anesthesia for post-surgical recovery. Solo-Dex technology is approved for clinical use in the U.S. and EU. About Polymedicure Limited Polymed is one of Indias most trusted names in medical devices, with a portfolio of more than 125 FDA-approved and CE-marked products. With a global presence in over 100 countries, Polymed operates high-end manufacturing facilities and is committed to delivering innovative, high-quality healthcare solutions at scale.


Indian Express
30 minutes ago
- Indian Express
Uttar Pradesh govt leases land for Hyderabad's varsity campus in Lucknow at Re 1 per year
The Uttar Pradesh government has transferred 2.32 hectares of land for the construction of a permanent campus of the English and Foreign Languages University, Hyderabad to promote quality education in English and foreign languages. The land is located in Chakauli village of Pargana Bijnor in the Sarojini Nagar tehsil of Lucknow district on lease at the rate of Re 1 per year, an official statement issued here said. At the permanent campus in Lucknow, the central university will run regular programmes like BA (Honours) English, MA English, MA Linguistics, MA English Literature, Post Graduate Diploma in the Teaching of English (PGDTE) and PhD along with part-time courses in French, German, Russian and Spanish languages. At present, the university is temporarily operating from a complex at Kanpur Road in Lucknow. At the land transfer ceremony on Tuesday, Higher Education Minister Yogendra Upadhyay, who was also the chief guest, said that the state government is committed to providing the youth of the state with linguistic education of global standards. He expressed confidence that the construction of the permanent campus will lead to unprecedented growth in the quality of education and facilities. The university's Vice Chancellor, Prof N Nagaraju, expressed gratitude towards the state government, saying that this land transfer is a historic step for the long-term development of the institution and that the Lucknow Campus will be developed into an excellent centre for linguistic education and research. The English and Foreign Languages University was formerly called the Central Institute of English and Foreign Languages (CIEFL). The university was founded in 1958 and was created by an Act of Parliament and came into being on August 3, 2007. The EFL University has three campuses — while the headquarters is in Hyderabad, the other two are in Lucknow and Shillong. ELFU Lucknow has been functioning since 1979 and the one in Shillong since 1973.


Economic Times
30 minutes ago
- Economic Times
ONGC shares in focus after mixed Q1 results
Shares of state-run Oil and Natural Gas Corporation (ONGC) are set to be in focus on Wednesday after the energy major posted a mixed set of first-quarter earnings, with profit growth contrasting a fall in revenue. ADVERTISEMENT The oil producer reported an 18.2% year-on-year increase in consolidated net profit to Rs 11,554.21 crore for the quarter ended June 2025, compared with Rs 9,776 crore a year earlier. However, consolidated revenue from operations slipped 3.2% to Rs 1,63,108 crore from Rs 1,68,967 crore in the same period last year. Standalone net profit fell 10.2% to Rs 8,024 crore from Rs 8,938 crore in Q1 FY26, though it rose 24% sequentially from the March quarter. Standalone revenue came in at Rs 32,003 crore, down 9.3% year-on-year and 9% lower than the previous quarter. EBITDA for the quarter was Rs 18,657 crore, a 2% decline from last year. 'Gas from new wells is eligible for a 20 per cent premium over the domestic APM gas price. ONGC is actively working to boost output from such wells. In Q1 FY26, revenue from new well gas stood at Rs 1,703 crore, delivering an additional Rs 333 crore compared to the APM gas price,' the company said in a press crude oil production rose 1.2% to 4.683 million metric tonnes (MMT) from 4.629 MMT a year ago, while standalone natural gas output was marginally lower at 4.846 billion cubic metres (BCM) compared with 4.863 BCM in Q1 FY25. ONGC also announced two offshore discoveries during the quarter in its operated acreages. ADVERTISEMENT ONGC shares have been under sustained pressure, falling 31% over the past 12 months and down 0.6% so far in 2025. Unlock 500+ Stock Recos on App From a technical standpoint, the stock is currently trading below seven of its eight key simple moving averages (SMA), including the 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day SMAs, but trading above its 5-day SMA. ADVERTISEMENT The Relative Strength Index (RSI) stands at 39, suggesting the stock is neither overbought nor oversold. Meanwhile, the Moving Average Convergence Divergence (MACD) is at -2.7 and remains below both the center and signal lines, reinforcing the ongoing bearish trend. Also read | Sebi looks to further ease regulations for foreign investors (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)